Receptor-interacting protein kinase-1 ablation in liver parenchymal cells promotes liver fibrosis in murine NASH without affecting other symptoms-Reference-Cited by-同舟云学术

Receptor-interacting protein kinase-1 ablation in liver parenchymal cells promotes liver fibrosis in murine NASH without affecting other symptoms

Published:2022-04-27 Issue:7 Volume:100 Page:1027-1038
ISSN:0946-2716
Container-title:Journal of Molecular Medicine
language:en
Short-container-title:J Mol Med

Author:

Farooq Muhammad^ORCID,Simoes Eugénio Mélanie^ORCID,Piquet-Pellorce Claire^ORCID,Dion Sarah^ORCID,Raguenes-Nicol Céline^ORCID,Santamaria Kathleen^ORCID,Kara-Ali Ghania Hounana^ORCID,Larcher Thibaut,Dimanche-Boitrel Marie-Thérèse^ORCID,Samson Michel^ORCID,Le Seyec Jacques^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Drug Discovery,Molecular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00109-022-02192-5.pdf

Reference51 articles.

1. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15:11–20. https://doi.org/10.1038/nrgastro.2017.109

2. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore, MD) 64:73–84. https://doi.org/10.1002/hep.28431

3. Calzadilla Bertot L, Adams LA (2016) The natural course of non-alcoholic fatty liver disease. Int J Mol Sci. https://doi.org/10.3390/ijms17050774

4. Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, Ahmed A (2015) Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 148:547–555. https://doi.org/10.1053/j.gastro.2014.11.039

5. Buzzetti E, Pinzani M, Tsochatzis EA (2016) The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism: clinical and experimental 65:1038–1048. https://doi.org/10.1016/j.metabol.2015.12.012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycolysis in hepatic stellate cells coordinates fibrogenic extracellular vesicle release spatially to amplify liver fibrosis;Science Advances;2024-06-28

2. RIPK1 in Liver Parenchymal Cells Limits Murine Hepatitis during Acute CCl4-Induced Liver Injury;International Journal of Molecular Sciences;2022-07-01

3. The scaffold-dependent function of RIPK1 in experimental non-alcoholic steatohepatitis;Journal of Molecular Medicine;2022-06-15